BRIDGE Project Launches to Advance Regulatory Sandboxes for Healthcare Innovation
The EU-funded BRIDGE project (Breakthrough Regulatory Innovation and Development throuGh sandbox Environments) aims to deliver a framework for regulatory sandboxes for emerging health technologies in Europe.
Professor Petra Ritter (BIH) participates in BRIDGE project
Professor Petra Ritter (head of the Brain Simulation Group at the BIH), and her team are part of the BRIDGE consortium. They contribute their expertise as leaders of the EU Testing and Experimentation Facility (TEF-Health) to the project. For more information about the project, please see below.
If you have any questions about the TEF-Health project, please feel free to contact Jasmin Podufall: jasmin.podufall@berlin-partner.de.
She manages Berlin Partner’s role within the TEF-Health consortium.
More information about IHI BRIDGE project
The project, which is a flagship of the Innovative Health Initiative (IHI), recognises that cutting-edge health innovations often do not fit neatly within existing regulatory frameworks, delaying their development and patient access. Regulatory sandbox mechanisms offer a way forward through experimentation.
Regulatory sandbox mechanisms offer a way to address this challenge by allowing innovators and regulators to collaborate early, test new approaches, and identify regulatory needs before a product or service reaches the market.
A major European initiative to support innovative health technologies
Cutting-edge health innovations often do not fit neatly within existing regulatory frameworks, delaying their development and patient access. Regulatory sandbox mechanisms offer a way forward through experimentation.
The implementation of regulatory sandboxes in healthcare is still in its early stages. In Europe, it remains only a concept in the biomedical and biotherapeutics field. Translating a concept into an effective tool is the challenge BRIDGE aims to address.
